We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

22 hedge funds and large institutions have $2.73M invested in Sonoma Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

22% more funds holding

Funds holding: 18 → 22 (+4)

0.01% more ownership

Funds ownership: 0.08% → 0.09% (+0.01%)

21% less capital invested

Capital invested by funds: $3.44M → $2.73M (-$708K)

Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$316K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$69K
3
PAM
Panagora Asset Management
Massachusetts
+$54.2K
4
RJA
Raymond James & Associates
Florida
+$50.1K
5
PGA
Premia Global Advisors
Florida
+$46K

Top Sellers

Rank Fund Capital Flow
1
BA
Bard Associates
Illinois
-$28.8K
2
Deutsche Bank
Deutsche Bank
Germany
-$22.2K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$1.21M -$28.8K -35 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$373K +$69K +84 +18%
SM
3
Sabby Management
Florida
$255K +$316K +384 New
Renaissance Technologies
4
Renaissance Technologies
New York
$217K +$822 +1 +0.3%
JAM
5
JW Asset Management
Florida
$151K – – –
BlackRock
6
BlackRock
New York
$106K +$822 +1 +0.6%
BRWA
7
B. Riley Wealth Advisors
Florida
$83K +$35.3K +43 +52%
Deutsche Bank
8
Deutsche Bank
Germany
$74K -$22.2K -27 -19%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$48K – – –
PAM
10
Panagora Asset Management
Massachusetts
$44K +$54.2K +66 New
GW
11
GW & Wade
Massachusetts
$41K +$822 +1 +2%
RJA
12
Raymond James & Associates
Florida
$41K +$50.1K +61 New
PGA
13
Premia Global Advisors
Florida
$36K +$46K +56 New
UBS Group
14
UBS Group
Switzerland
$17K +$822 +1 +4%
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$15K – – –
Morgan Stanley
16
Morgan Stanley
New York
$12K – – –
Wells Fargo
17
Wells Fargo
California
$4K – – –
Bank of America
18
Bank of America
North Carolina
$2K – – –
BCP
19
Blackhawk Capital Partners
Wisconsin
$2K – – –
HFM
20
Hartford Financial Management
Connecticut
$1K – – –
GI
21
Gradient Investments
Minnesota
$1K +$1.64K +2 New
RE
22
RBC Europe
United Kingdom
$92 – – –
Bank of Montreal
23
Bank of Montreal
Ontario, Canada
– -$3K -3 Closed

SNOA Hedge Fund Activity: Q1 2018 in Review

22 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q1 2018, worth a combined $2.73M — down 21% from $3.44M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SNOA positions and 1 closed out — a net gain of 4 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $316K. The largest seller was Bard Associates, cutting an estimated $28.8K.

  • 22 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q1 2018, up from 18 in Q4 2017.
  • Funds reported $2.73M of Sonoma Pharmaceuticals stock for Q1 2018, down 21% quarter-over-quarter.
  • 5 funds opened new Sonoma Pharmaceuticals positions in Q1 2018 and 1 closed out, a net change of +4 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q1 2018 was Sabby Management, an estimated $316K added.
  • The largest Sonoma Pharmaceuticals seller in Q1 2018 was Bard Associates, an estimated $28.8K sold.

Based on aggregated 13F filings for Q1 2018.